About: Omadacycline Enters the Ring: A New Antimicrobial Contender

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Omadacycline Enters the Ring: A New Antimicrobial Contender Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 15 November 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) im Oktober 2018 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 2018 (ast) наукова стаття, опублікована в жовтні 2018 (uk) scientific article published on 15 November 2018 (en)
publication date	wds:Q56985069-740BFEF5-850E-4647-8C85-DEEC58736276 wds:Q56985069-A19A01CC-0581-46FF-A43D-4569A34C264B
publication date	2018-11-15 00:00:00Z (xsd:dateTime) 2018-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56985069-1CE9F5ED-D158-4F85-B5A1-D5D1CEB082E6
language of work or name	English
cites work	wds:Q56985069-044AD453-07B2-4318-B270-305B76A99032 wds:Q56985069-0B271755-840A-4423-88DE-F057EEFB1601 wds:Q56985069-126226B8-C88E-4DF1-86DB-167F178127A7 wds:Q56985069-2FA13C31-B286-464C-8FAE-5E21855BEF74 wds:Q56985069-3BD57D8A-A488-4250-BDA2-3D41E8DECC3B wds:Q56985069-452D0412-51E4-41DD-B890-6FD964E42964 wds:Q56985069-470BACAE-ADB6-4622-8640-71BD32B67065 wds:Q56985069-6692467F-A6DB-4DFA-9CB7-0FB866AD2BBD wds:Q56985069-68846630-0C70-453D-8337-D9EAB386675D wds:Q56985069-70D88311-BD73-4F24-ABCF-E6B2B3BC2875 wds:Q56985069-7BD81E1A-2429-41F2-86E9-7792EC193AFD wds:Q56985069-99DA8E4A-B259-43FC-9C6C-6A99E9753079 wds:Q56985069-A0850F29-47B5-47EE-861D-B25481D1D2C2 wds:Q56985069-ABA697B3-9D06-4B16-AA9F-638AB61F8683 wds:Q56985069-AF62B9E6-BBA5-42DF-BEC7-5387E621DFFC wds:Q56985069-BD32490A-6C1C-436C-B0B8-20BCD32AC1B7 wds:Q56985069-C091B05B-F844-469E-9DB7-4576803E5E41 wds:Q56985069-C5218FEF-B6DE-4040-A268-8AF65842A4CD wds:Q56985069-C80E1F48-E361-4F84-8756-33EB23468BC6 wds:Q56985069-C86A9131-0EEA-4529-8D93-EC4CA5A37730 wds:Q56985069-C90E4573-4A88-4E22-9D70-F3BF094457AB wds:Q56985069-EA8D1F13-33A3-46F2-A401-3DA4130A497B wds:Q56985069-EEC934CC-7397-4A04-944A-5C28F5EC124C wds:Q56985069-F962F15E-541D-4D14-85F7-92313A64527B
cites work	Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome Mechanism of action of the novel aminomethylcycline antibiotic omadacycline. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects Effect of Food on the Bioavailability of Omadacycline in Healthy Participants Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011. In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model. In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline. A Review on Antibiotic Resistance: Alarm Bells are Ringing Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program. The In Vitro Activity of Omadacycline and Comparators Against Anaerobic Bacteria. Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014). In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis Pharmacokinetics and Safety of Omadacycline in Subjects With Impaired Renal Function. Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose Regimens. Omadacycline: comparative in vitro activity against dog and cat bite wound isolates.
author name string	wds:Q56985069-6323D1A9-EDED-4B26-A453-B6437CC0669E wds:Q56985069-BD37D49C-413A-4CF9-BED9-115F779749F6
author name string	Alison M Bell Mary Joyce B Wingler
rdfs:label	Omadacycline Enters the Ring: A New Antimicrobial Contender (en) Omadacycline Enters the Ring: A New Antimicrobial Contender (nl)
skos:prefLabel	Omadacycline Enters the Ring: A New Antimicrobial Contender (en) Omadacycline Enters the Ring: A New Antimicrobial Contender (nl)
name	Omadacycline Enters the Ring: A New Antimicrobial Contender (en) Omadacycline Enters the Ring: A New Antimicrobial Contender (nl)
author	wds:Q56985069-5F5D8B14-E24D-4B2E-9313-28BF5F593A38 wds:Q56985069-74A4ADA6-8B5F-4A35-81CD-0086AF7709B9 wds:Q56985069-F167E5BC-FD46-44C8-8329-378D3FE1F4A6
author	Katie E Barber Jamie L. Wagner Kayla R Stover
title	wds:Q56985069-F591ABEB-7F8C-46EE-8C09-6BEDAFE00B65
title	Omadacycline Enters the Ring: A New Antimicrobial Contender (en)
page(s)	wds:Q56985069-C55CDAD7-1042-4024-8293-BB5D31522503
page(s)	1194-1204
instance of	wds:Q56985069-C76B66CA-FEEE-481F-BCB1-FA2E23EFD3ED wds:Q56985069-FE2DB39A-F6C5-44F3-AF29-40BA38FA2447
instance of	review article scholarly article
main subject	wds:Q56985069-63A0F9BA-733E-44E2-845A-DD6E7F363E72 wds:Q56985069-C155CC7F-8BC9-47F7-89BC-5F8BDF671485
main subject	community acquired infection drug approval
PubMed ID	wds:Q56985069-6FD25444-A46E-45D6-B7D9-9296D494497A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30290000
PubMed ID	30290000
published in	wds:Q56985069-46DE58DB-7391-42F6-8671-0CBB6E422793
published in	Pharmacotherapy
issue	wds:Q56985069-4E5BCB96-C6AE-4741-81D8-75269C184A87
volume	wds:Q56985069-EB55EA46-660E-4830-8466-9D7E0751E498
issue	12
volume	38
DOI	wds:Q56985069-517007F0-8C08-48D3-9A3F-5E18F9309CA9
DOI	http://dx.doi.org/10.1002/PHAR.2185
DOI	10.1002/PHAR.2185

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software